Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Reduction in the number of lymphocytes.
Biomarker and diagnostic research for lymphopenia has been reported in the published literature.
28 clinical trials registered, 12 recruiting. Interventions under study include drug therapy, biologic therapy, other interventions, and procedural interventions. Pipeline includes 3 PHASE3, 9 PHASE2, 5 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07146737](https://clinicaltrials.gov/study/NCT07146737) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:52 PM UTC
Predictive Performance of a Generative Model for Corneal Tomography After ICL Implantation |
— |
Second Affiliated Hospital of Nanchang University |
RECRUITING |
[NCT03394053](https://clinicaltrials.gov/study/NCT03394053) | The Mechanistic Biology of Primary Immunodeficiency Disorders | — | National Institute of Allergy and Infectious Diseases (NIAID) | RECRUITING |
[NCT01962415](https://clinicaltrials.gov/study/NCT01962415) | Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT | PHASE2 | Paul Szabolcs | RECRUITING |
[NCT07111598](https://clinicaltrials.gov/study/NCT07111598) | Immunological Effects of Iron Supplementation in HHT Disease | NA | Hospices Civils de Lyon | RECRUITING |
[NCT04528355](https://clinicaltrials.gov/study/NCT04528355) | Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC | — | Paul Szabolcs | RECRUITING |
399 publications have been identified in PubMed for lymphopenia. Kisho has analyzed 126 by research type. Research spans Epidemiology / Natural History (28%), Basic Science / Preclinical (20%), and Review / Meta-Analysis (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 35 | 28% |
Laboratory research | 25 | 20% |
Research summaries | 24 | 19% |
Clinical study results | 24 | 19% |
Testing and diagnosis research | 7 | 6% |
Patient case studies | 6 | 5% |
New treatment approaches | 4 | 3% |
Other research | 1 | 1% |
de Kermenguy F (2026). [PMID: 40763901](https://pubmed.ncbi.nlm.nih.gov/40763901/). *Int J Radiat Oncol Biol Phys*. [Review / Meta-Analysis]
Wang Z (2026). [PMID: 41362159](https://pubmed.ncbi.nlm.nih.gov/41362159/). *Emerg Microbes Infect*. [Epidemiology / Natural History]
van Bergen T (2026). [PMID: 41056520](https://pubmed.ncbi.nlm.nih.gov/41056520/). *Blood Adv*. [Gene Therapy / Novel Therapeutics]
Coupey J (2026). [PMID: 41547377](https://pubmed.ncbi.nlm.nih.gov/41547377/). *Int J Radiat Oncol Biol Phys*. [Clinical Trial Publication]
Terteşş R (2026). [PMID: 41751337](https://pubmed.ncbi.nlm.nih.gov/41751337/). *Biomedicines*. [Basic Science / Preclinical]
Ghosh S (2026). [PMID: 41971628](https://pubmed.ncbi.nlm.nih.gov/41971628/). *J Hum Immun*. [Basic Science / Preclinical]
Lu X (2026). [PMID: 42055480](https://pubmed.ncbi.nlm.nih.gov/42055480/). *Respir Med*. [Review / Meta-Analysis]
Gunderman LM (2026). [PMID: 42088107](https://pubmed.ncbi.nlm.nih.gov/42088107/). *J Hum Immun*. [Basic Science / Preclinical]
Schaff LR (2026). [PMID: 41557853](https://pubmed.ncbi.nlm.nih.gov/41557853/). *Neuro Oncol*. [Clinical Trial Publication]
Jiang Z (2026). [PMID: 41354206](https://pubmed.ncbi.nlm.nih.gov/41354206/). *Int J Infect Dis*. [Epidemiology / Natural History]